Pathogens Enzyme-Based Anthrax Therapy Shows Promise in Preclinical TrialsGlobal Biodefense StaffJune 17, 2025
Medical Countermeasures Novel Oral Chitosan-Based Compound Shows Promise for Radiological Emergency ResponseGlobal Biodefense StaffJune 12, 2025
Medical Countermeasures Single-Dose VSV Vaccine Fully Protects Mice Against Crimean-Congo Hemorrhagic FeverGlobal Biodefense StaffJune 5, 2025
Nanotherapeutics Awarded $135M for Medical Countermeasures Advanced Development Defense + Military March 23, 2013 …
Anthrax Vaccine Trial for Kids? The Ethics of Pediatric Countermeasures Research Medical Countermeasures March 19, 2013 …
JPM-TMT Seeks Solutions to Multi-Drug Resistant Biowarfare Agents Antimicrobial Resistance March 12, 2013 …
Industry Day for Advancing Medical Countermeasure Regulatory Science Contracts + Grants March 11, 2013 …
Ragon Institute Brings New Perspectives to Vaccine Development Medical Countermeasures March 4, 2013 …
SEB Biodefense Vaccine Starts First Human Clinical Trial Antimicrobial Resistance February 26, 2013 …
